
Will traditional PBMs adapt, or will disruptors take over?

Will traditional PBMs adapt, or will disruptors take over?

About 59.2% of patients with tardive dyskinesia (TD) who completed the 48-week trial achieved remission.

Older age and being insured with Medicare or Medicaid were associated with heightened annual joint bleeding rates, whereas treatment in the Northeast United States improved outcomes in both hemophilia A and hemophilia B.

Managing the challenge requires a multifaceted approach with all stakeholders.

Gepotidacin is indicated for female patients who are at least 12 years of age and weigh at least 40 kg with uncomplicated urinary tract infections (uUTIs) caused by certain microorganisms.

Although PBMs claim integration reduces costs and improves efficiency, the reality is more complicated—and often leaves patients footing the bill.

A district leader at CVS Health emphasizes that patients should get tested, be up to date with immunizations, and staying home and reach out to health care professionals when experiencing symptoms.

Pharmacy technicians can elevate their careers by developing leadership skills, pursuing specialized certifications, and embracing continuous professional growth.

The legislation is expected to improve the financial stability of independent and community pharmacies by ensuring fair reimbursement rates and allowing them to better manage their finances.

National Adverse Drug Event Awareness Day was established to promote awareness, drive policy changes, and encourage health care professionals and patients to prioritize medication safety.

Expert offers insights into managing stress and preventing burnout in pharmacy leadership


Automation can enhance medication management and support pharmacists' critical clinical roles.

Jeff A. Goad, PharmD, MPH, discusses the latest RSV vaccination guidelines and recommendations for 2025, highlighting vaccine options, target populations, timing considerations, evolving CDC policies, and the role of pharmacists in immunization efforts.

In a debate at the 2025 APhA Annual Meeting, speakers highlighted GLP-1s’ advantages in stroke prevention and weight loss vs SGLT2s’ superiority in heart failure, CV death reduction, and renal protection.

Pharmacists are pivotal in expanding reproductive health care access through patient education and collaboration.

Pharmacists are leading the way in personalized medicine through strategic pharmacogenetic implementation.

Pharmacists can empower patient RSV vaccination through strategic communication and personalized care.

Two pharmacists at the 2025 APhA Annual Meeting debate the role of continuous glucose monitoring (CGM) for non-insulin users, highlighting evolving guidelines, emerging clinical evidence, cost and coverage challenges, and the need for further research to justify widespread adoption.

Pharmacists can navigate career paths through passion, adaptability, and patient-centered soft skills.

AI is offering new ways to support pharmacists' decision-making and patient care.

Contraceptive options have expanded since 1960, with pharmacists today playing a growing role as prescribers of contraception and studies showing the benefit of pharmacist-driven contraception clinics.

Community pharmacies can enhance medication safety by proactively identifying risks and implementing targeted best practices.

Sally Arif, PharmD, BCCP, discusses her presentation on the critical role of pharmacists in addressing health disparities by improving communication, fostering cultural competence, and promoting pharmacoequity.

The study aims to address lingering public concerns, but its findings and communication have the potential to impact vaccine confidence and public health efforts.

Nakia Eldridge, PharmD, MBA, shares insights for health system and community pharmacists attending the 2025 APhA Annual Meeting & Exposition.

Allison Ju-Chen Hu, PhD and Yuhua Bao, PhD describe results of their landmark study that found significant differences in opioid prescriptions in racially and ethnically minoritized communities.

As cases rise, experts warn that vitamin A supplementation should not be used as a replacement for vaccination.


The launch of ustekinumab-stba following its FDA approval expands patient access to this therapy with a variety of indications.